You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 November 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI), which focuses on rare diseases, said on Tuesday that the European Commission has approved Tryngolza (olezarsen) for adults with severe hypertriglyceridaemia (sHTG).It is the first...
17 November 2026 - Norwegian biotech company Oncoinvent ASA (OSE:ONCIN) on Tuesday reported favourable safety and tolerability results from the first interim safety analysis of its randomised phase 2 trial evaluating Radspherin in patients with advan...
17 November 2026 - Canadian pharmaceutical company Apotex Health Corp (TSX:APTX) announced on Monday the US launch of Axitinib Tablets, 1 mg and 5 mg, the first generic version of Pfizer's INLYTA, a kinase inhibitor indicated for the treatment o...
17 November 2026 - Biotechnology company Rakuten Medical Inc announced on Monday that it has initiated a Phase 1 clinical trial of RM-0256 photoimmunotherapy in Japan.RM-0256, an anti-PD-L1 antibody-light-activatable dye conjugate, is the third drug ...
17 November 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) said on Tuesday that its Japanese partner Eisai Co Ltd (TYO:4523) has presented new five-year data from the Clarity AD study and its long-term extension, showing in...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe